Tag: biotech stocks

Market News

Microsoft Q4 Earnings: Analyst Predictions Unveiled

Microsoft’s Q4 earnings are dropping soon! Analysts predict big gains, but will Azure steal the show again? Dive into the...

30/07/2025

7 views

Read More

Stocks

Stock Market Movers: Key Trends to Watch This Week

Which stocks are shaking up the market this week? From tech giants to fintech disruptors, uncover the trends driving tomorrow’s...

30/07/2025

5 views

Read More

Market News

Why Figma’s IPO Buzz Might Not Be Worth the Hype

Figma’s IPO is generating buzz, but is it too pricey? Explore why this design software star might not be the...

30/07/2025

13 views

Read More

Market News

Top Stocks Moving Premarket: Key Movers to Watch

Which stocks are surging before the bell? From biotech breakthroughs to industrial deals, uncover the biggest premarket movers and what...

29/07/2025

5 views

Read More

Market News

Sarepta’s Elevidys: FDA Lifts Pause, Shares Surge

Sarepta’s Elevidys gets FDA green light to resume, sending shares soaring. What does this mean for the future of gene...

29/07/2025

8 views

Read More

Global Markets

Samsung’s $16.5B Chip Deal Boosts Market Confidence

Samsung's $16.5B chip deal sends shares soaring! What does this mean for tech investors and global markets? Dive into the...

28/07/2025

5 views

Read More

Market News

Big Tech Earnings: What to Expect This Week

Big Tech earnings are here! Will Meta, Microsoft, Amazon, and Apple exceed expectations? Dive into our analysis to find out...

27/07/2025

11 views

Read More

Growth Picks

Palantir’s Meteoric Rise: A Tech Titan’s Triumph in 2025

Palantir’s stock skyrockets in 2025, hitting a $375B market cap. What’s driving this tech giant’s rise to the top 20...

25/07/2025

19 views

Read More

Market News

Top Stocks Surge: Tesla, Intel, Deckers Lead Market

Tesla soars, Intel dips, and Deckers shines in today’s market. What’s driving these moves, and how can you profit? Dive...

25/07/2025

10 views

Read More

Market News

Sarepta Stock Crashes After Europe Rejects Gene Therapy

Sarepta Therapeutics faces a brutal stock crash after Europe rejects its gene therapy drug Elevidys. What does this mean for...

25/07/2025

6 views

Read More